Kromek Group (LSE: KMK) supplies containment detection technology focusing on the medical, security screening and nuclear markets. Today it won a 7-year contract with a US based OME worth an estimated $17m for identifying contaminants during production processes as part of quality inspection.
For the Covid year-ended April 2021 revenue fell 30% to £10.1m with a loss of £6.3m down from £18m, as it accelerates further into the commercialisation phase. In March 2021 £13m was raised at 15p.
There are 24 new customers in the civil nuclear segment with widening interest for its drone-based ...
